Feasibility and Successful Enrollment in a Proof-of-Concept HIV Prevention Trial of VRC01, a Broadly Neutralizing HIV-1 Monoclonal AntibodySrilatha Edupuganti, P. Andrew, Erika Rudnicki et al.|JAIDS Journal of Acquired Immune Deficiency Syndromes|2021Cited by 26
Feasibility and Successful Enrollment in a Proof-of-Concept HIV Prevention Trial of VRC01, a Broadly Neutralizing HIV-1 Monoclonal AntibodyDavid Burns, Gail Broder, John Hural et al.|UNC Libraries|2023Cited by 0